While antibiotics have transformed modern medicine, helped to extend life expectancy in the UK by as much as 20 years and saved millions of lives around the world, the rapid rise of resistance to these drugs presents an imminent global health disaster if not adequately managed in the very near future. In this exclusive interview, we speak with Professor Colin Garner, founder and Chief Executive of Antibiotic Research UK, the world’s first charity focussing on bacterial antibiotic resistance, to hear about their vital efforts targeted at overcoming the challenge of antibiotic resistance.

Founded in 1992, Alzheimer’s Research UK is the UK’s leading dementia research charity. Their work is dedicated to furthering our understanding of the causes, diagnosis, prevention, treatment and cure of diseases such as Alzheimer’s. Characterised by declines in memory and other cognitive functions such as thinking and reasoning, these progressively worsening neurodegenerative and ultimately fatal diseases sadly remain without a cure. In this exclusive interview, we speak with Ian Wilson, Deputy Chief Executive, to hear about the vital work conducted by Alzheimer’s Research UK.

Bacteria are found everywhere – in humans, animals and the environment – and are best known for being able to cause painful and even fatal infections. It may come as surprise, therefore, to learn that bacteria can also have useful applications. The lifetime work of Dr Bert Lampson at East Tennessee State University in the USA has focussed on the dangers and applications of bacteria. Over his career, Dr Lampson has discovered new mechanisms of antibiotic resistance, novel antibiotics, and bacterial proteins, with important applications for science and healthcare.